Clinical Trials on Advanced MDS in Belgium
Total 269 results
-
Groupe Francophone des MyelodysplasiesNovartisUnknown
-
Celyad Oncology SAIQVIA BiotechCompletedAML | MDSUnited States, Belgium
-
iTeos Belgium SACompleted
-
AZ-VUBAstraZeneca; Kom Op Tegen KankerRecruitingAdvanced Cancers Harbouring Mutations in HRGBelgium
-
Jules Bordet InstituteUniversité Libre de Bruxelles; Fonds Gaston Ithier; Association Jules BordetRecruiting
-
Stichting Hemato-Oncologie voor Volwassenen NederlandSwiss Group for Clinical Cancer ResearchActive, not recruitingAML/MDSNetherlands, Belgium, Germany, Switzerland
-
Universitair Ziekenhuis BrusselCompletedAdvance Care Planning | Ethnic Minorities | Moroccans | Advance Medical Directives | Muslims | Living WillBelgium
-
OnxeoCompletedAdvanced CancerFrance, Belgium
-
Universitair Ziekenhuis BrusselCompletedAdvance Care Planning | Ethnic Minorities | Advance Medical Directives | Muslims | Living Will | Turkish OriginBelgium
-
Cell Medica LtdUniversity College, London; Cell Therapy CatapultCompletedMyelodysplastic Syndromes (MDS) | Acute Myeloid Leukaemia (AML)United Kingdom, Germany, Belgium
-
Exscientia AI LimitedBiotrialTerminatedAdvanced Solid TumoursFrance, Belgium
-
MonTa Biosciences ApSAllucentRecruitingAdvanced Solid TumorBelgium, Denmark, Spain
-
Kling Biotherapeutics B.V.RecruitingAdvanced Solid Tumor MalignancyBelgium, Netherlands
-
Taiho Oncology, Inc.CompletedAdvanced Solid TumorsFrance, Belgium, Italy, Switzerland
-
End-of-Life Research GroupCompletedElderly Care | Advance Care Planning | Nursing HomeBelgium
-
Universitair Ziekenhuis BrusselCompletedAdvance Care Planning | Family Caregivers | Ethnic MinoritiesBelgium
-
PharmaMarRecruitingAdvanced Solid TumorBelgium, United States, Spain
-
European Society for Blood and Marrow TransplantationNovartisCompletedMDS | CMMLGermany, Belgium, Czechia
-
University Hospital, GhentUniversity Ghent; Het LezerscollectiefCompletedAcute Leukemia | Advanced Solid TumorBelgium
-
Exscientia AI LimitedGT Apeiron LLCRecruitingAdvanced Solid TumorUnited Kingdom, Belgium
-
Bristol-Myers SquibbCompletedAdvanced CancerUnited States, Belgium, Canada
-
Lupin Ltd.CompletedA Study of LNP3794 in Subjects With NRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsNRAS/KRAS Mutated Advanced or Metastatic Refractory Solid TumorsUnited Kingdom, Netherlands, Belgium
-
Novartis PharmaceuticalsCompletedMyelodysplastic Syndrome (MDS)France, Spain, Belgium, Italy, Greece, Hungary, Germany
-
Eli Lilly and CompanyCompletedAdvanced CancerBelgium, United States, Korea, Republic of, Australia, France
-
Xenothera SASRecruitingMetastatic Cancer | Advanced Solid TumorFrance, Belgium
-
University Hospital, GhentCompletedAdvanced Colorectal CancerBelgium
-
T-knife GmbHTerminatedAdvanced Solid TumorsGermany, Belgium, Spain, Netherlands, United Kingdom
-
AmgenCompletedAdvanced Solid TumorsUnited States, Belgium, Spain, Australia
-
Clavis PharmaCompletedAdvanced Adenocarcinoma of PancreasNorway, Belgium
-
Vrije Universiteit BrusselKing's College London; University of Copenhagen; Erasmus Medical Center; University... and other collaboratorsActive, not recruitingAdvanced CancerBelgium, Netherlands, Denmark, Ireland, United Kingdom, Italy
-
PfizerTerminatedAdvanced Breast Cancer (Parts 1 and 2) | Advanced Pancreatic Cancer (Part 1) | Advanced Colorectal Cancer (Part 1) | Advanced Cholangiocarcinoma (Part 1) | Advanced Glioblastoma Multiforme (Part 1)United States, Spain, Hong Kong, Belgium, Australia, France
-
Jean-Luc Van LaethemCelgene CorporationCompletedPancreatic Adenocarcinoma Resectable | Pancreatic Adenocarcinoma Metastatic | Pancreatic Adenocarcinoma Locally AdvancedBelgium
-
ElmediXRecruitingAdvanced Cancer | Pancreatic Cancer MetastaticBelgium
-
Bristol-Myers SquibbTerminatedAdvanced CancerUnited States, Netherlands, Australia, Belgium, Canada, Italy, United Kingdom
-
SOTIO Biotech AGRecruitingAdvanced Solid Tumor | Metastatic Solid TumorUnited States, Spain, Czechia, Belgium, France
-
Novartis PharmaceuticalsCompletedcMET-dysregulated Advanced Solid TumorsUnited States, Italy, Spain, United Kingdom, Greece, Belgium, Austria, Czechia
-
University Hospital, GhentCompletedLocally Advanced and Unresectable, But Non-metastatic Pancreatic Adenocarcinoma or CholangiocarcinomaBelgium
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedAdvanced Solid TumorsUnited States, Germany, Norway, Netherlands, Belgium, Denmark, Sweden, Switzerland
-
AmgenCompletedAdvanced Solid TumorsBelgium, Canada, Australia, United States, Spain, Poland, France, Germany, Japan, United Kingdom
-
Novartis PharmaceuticalsCompletedMetastatic or Locally Advanced Solid TumorsNetherlands, Spain, Germany, Switzerland, Belgium
-
BayerCompletedCarcinoma, Renal Cell | Carcinoma, Renal Cell (Advanced)Belgium
-
Pyxis Oncology, IncRecruiting
-
Jules Bordet InstituteCompletedAdvanced Chemorefractory Colorectal AdenocarcinomaBelgium
-
Novartis PharmaceuticalsNantCell, Inc.TerminatedPIK3CA Mutated Advanced Solid Tumors | PIK3CA Amplified Advanced Solid TumorsSpain, Belgium, United States, Canada
-
OSE ImmunotherapeuticsRecruitingDose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or LymphomasLymphoma | Solid Advanced TumorFrance, Belgium
-
BayerCompletedAdvanced or Metastatic Solid TumorUnited States, Spain, Korea, Republic of, Belgium, Singapore, Germany
-
Hoffmann-La RocheCompletedAdvanced/Metastatic Solid TumorsUnited States, Belgium, Denmark, Spain, Netherlands, Canada, Italy
-
Universitaire Ziekenhuizen KU LeuvenAZ Sint-Jan AV; General Hospital Groeninge; AZ Sint-Blasius DendermondeRecruitingProstate Cancer | Adenocarcinoma of the Prostate | Locally Advanced Prostate Carcinoma | Locally Advanced Prostate AdenocarcinomaBelgium
-
AmgenCompletedMDSGermany, Italy, Belgium, Czechia, Switzerland, France, Austria, Greece, Spain